Valion Bio Statistics
NASDAQ: VBIOHealthcareBiotechnologyUSD
2.21+0.02 (+0.91%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Valion Bio by the numbers
Valion Bio has a market capitalization of $2.0 million based on 887.59K shares outstanding. With trailing EPS of $-177.91, Valion Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 41.9% below its 50-day average and 87.7% below its 200-day average.
Average daily trading volume is 1.46M shares, or about $3.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
VBIO valuation vs. peer median
| Metric | VBIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.96M | $1.86M | +5% |
| Avg. volume | 1.46M | 638.96K | +129% |
Peer median across 8 companies: LABT, ARTL, OGEN, EDVA, CRIS, GNPX, SCNI, TCRT.
Valuation
- Market cap
- $1.96M
- EPS (TTM)
- $-177.91
- Shares outstanding
- 887.59K
Price and trading
- Previous close
- 2.19
- Open
- 2.07
- Day range
- 2.07 – 2.28
- 52-week range
- 2.05 – 76.50
- Beta
- —
- Volume
- 149.98K
- Average volume
- 1.46M
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 1.96M
- Eps
- -177.91
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 76.50
- Week52 Low
- 2.05
- Avg Volume
- 1.46M
- Shares Outstanding
- 887.59K
- Ma50
- 3.80
- Ma200
- 18.00
- Pct From52w High
- -97.11%
- Pct From52w Low
- 7.80%